SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Adorbs Inc. – ‘10-12G/A’ on 11/18/20 – ‘EX-99.23’

On:  Wednesday, 11/18/20, at 2:34pm ET   ·   Accession #:  1213900-20-37931   ·   File #:  0-56213

Previous ‘10-12G’:  ‘10-12G’ on 10/7/20   ·   Next:  ‘10-12G/A’ on 12/14/20   ·   Latest:  ‘10-12G/A’ on 12/22/20   ·   15 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

11/18/20  Adorbs Inc.                       10-12G/A               6:838K                                   EdgarAgents LLC/FA

Amendment to Registration Statement   —   Form 10   —   Sect. 12(g) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-12G/A    Amendment No. 1 to Form 10-12G                      HTML    333K 
 2: EX-99.22    Demand Promissory Note Payable to Activist          HTML     11K 
                Investing LLC                                                    
 3: EX-99.23    Demand Promissory Note Payable to Rebecca Lazar     HTML     11K 
 4: EX-99.24    Consent of Independent Auditor                      HTML      5K 
 5: EX-99.25    Consent of Prior Independent Auditor                HTML      6K 
 6: EX-99.26    Michael Gillespie & Associates, Pllc No             HTML      6K 
                Disagreement Letter to the Securities and Exchange               
                Commission                                                       


‘EX-99.23’   —   Demand Promissory Note Payable to Rebecca Lazar


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



Exhibit 23

 

DEMAND PROMISSORY NOTE

 

Amount: $69,136 Date: June 30, 2020

 

FOR VALUE RECEIVED, Adorbs Inc. whose address is 234 E. Beach Street, Long Beach, NY 11561 (hereinafter the “Maker”) promises to pay to the order of Rebecca Lazar (the “Holder”) at 1185 Avenue of the Americas, 3rd Floor, New York, or at such other place as the holder hereof shall designate to the undersigned in writing, in lawful money of the United States of America, the principal amount of sixty-nine thousand, one hundred and thirty-six dollars ($69,136) on demand by the Holder (the “Demand Date”).

 

In the event the principal hereunder shall remain unpaid for a period of ten (30) days or more following the Demand Date, a late charge equivalent to one (1%) percent of such payment shall be charged. In the event of default in any payment due under this demand promissory note, which remains unpaid for a period of ten days or more, the principal and accrued interest amount shall immediately become due and payable without any further demand or request.

 

If any payment of principal or interest on this Note becomes due and payable on a Saturday, Sunday or public holiday under the laws of the State of New York, the due date hereof shall be extended to the next succeeding full business day. All payments received by the holder shall be applied first to the payment of accrued interest and then to principal.

 

This Note may be prepaid in whole or in part at any time.

 

In the event that this Note shall be placed in the hands of an attorney for collection by reason of any default hereunder, the undersigned agrees to pay reasonable attorney’s fees and disbursements and other reasonable expenses incurred by the payee in connection with the collection of this Note.

 

The rights, powers and remedies given to the payee under this Note shall be in addition to all rights, powers and remedies given to it by virtue of any statute or rule of law.

 

Any forbearance, failure or delay by the payee in exercising any right, power or remedy under this Note or otherwise available to the payee shall not be deemed to be a waiver of such right, power or remedy, nor shall any single or partial exercise of any right, power or remedy preclude the further exercise thereof.

 

No modification or waiver of any provision of this Note shall be effective unless it shall be in writing and signed by the payee, and any such modification or waiver shall apply only in the specific instance for which given.

 

This Note and the rights and obligations of the parties hereto, shall be governed, construed and interpreted according to the laws of the State of New York wherein it was negotiated and executed, and the undersigned consents and agrees that the State and Federal Courts which sit in the State of New York and the County of New York shall have exclusive jurisdiction of all controversies and disputes arising hereunder.

 

The undersigned waives the right in any litigation with the payee to trial by jury.

 

The term “payee” as used herein shall be deemed to include the payee and its successors, endorsees and assigns.

 

The undersigned hereby jointly and severally waive presentment, demand for payment, protest, notice or protest and notice of non-payment hereof.

 

Adorbs Inc.  
     
By: /s/ David Lazar  
Name: David Lazar  
Its: CEO  

 


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-12G/A’ Filing    Date    Other Filings
Filed on:11/18/20CORRESP
6/30/20
 List all Filings 


14 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

11/20/23  Adorbs Inc.                       10-Q        9/30/23   41:2.4M                                   Empire Filings/FA
 9/27/23  Soul Biotechnology Corp.          10-Q        6/30/23   41:2.4M                                   Empire Filings/FA
 5/15/23  Soul Biotechnology Corp.          10-Q        3/31/23   38:2.2M                                   Empire Filings/FA
10/21/22  Soul Biotechnology Corp.          10-Q        9/30/22   38:2.4M                                   Empire Filings/FA
 8/01/22  Soul Biotechnology Corp.          10-Q        6/30/22   38:2.1M                                   Empire Filings/FA
 5/10/22  Soul Biotechnology Corp.          10-Q        3/31/22   38:1.8M                                   Empire Filings/FA
 2/08/22  Soul Biotechnology Corp.          10-K       12/31/21   29:1.4M                                   Empire Filings/FA
12/09/21  Soul Biotechnology Corp.          10-K/A     12/31/20   28:1M                                     Empire Filings/FA
10/13/21  Soul Biotechnology Corp.          10-Q        9/30/21   29:1.3M                                   Empire Filings/FA
 7/23/21  Soul Biotechnology Corp.          10-Q        6/30/21   29:1.3M                                   Empire Filings/FA
 5/03/21  Soul Biotechnology Corp.          10-Q        3/31/21   28:926K                                   EdgarAgents LLC/FA
 2/10/21  Soul Biotechnology Corp.          10-K       12/31/20   28:1.1M                                   EdgarAgents LLC/FA
12/22/20  Soul Biotechnology Corp.          10-12G/A               4:704K                                   EdgarAgents LLC/FA
12/14/20  Soul Biotechnology Corp.          10-12G/A               5:709K                                   EdgarAgents LLC/FA


1 Previous Filing that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 1/19/18  Soul Biotechnology Corp.          S-1                    6:1M                                     S2 Filings LLC/FA
Top
Filing Submission 0001213900-20-037931   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sat., Apr. 27, 11:07:29.1am ET